Company profile for RespireRx Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

RespireRx Pharmaceuticals Inc. is a leader in the development of medicines for respiratory disorders and CNS indications, with a focus on obstructive sleep apnea, attention deficit hyperactivity disorder (ADHD), spinal cord injury and other neurological conditions. The Company owns and has exclusive rights to patents and patent applications for certain families of chemical compounds that claim the chemical structures, formul...
RespireRx Pharmaceuticals Inc. is a leader in the development of medicines for respiratory disorders and CNS indications, with a focus on obstructive sleep apnea, attention deficit hyperactivity disorder (ADHD), spinal cord injury and other neurological conditions. The Company owns and has exclusive rights to patents and patent applications for certain families of chemical compounds that claim the chemical structures, formulations and their uses in the treatment of a variety of disorders, as well as claims for novel uses of known drugs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
126 Valley Road, Suite C Glen Rock, New Jersey 07452
Telephone
Telephone
(917) 834-7206
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/20/3192053/0/en/RespireRx-Pharmaceuticals-Inc-CFO-and-CEO-Issue-Letter-to-Stockholders-Stakeholders-Strategic-and-Potential-Strategic-Partners-and-Other-Interested-Parties.html

GLOBENEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/11/19/3191081/0/en/RespireRx-Pharmaceuticals-Inc-Announces-NIH-NINDS-Grant-Award-and-Amended-and-Restated-Patent-License-Agreement.html

GLOBENEWSWIRE
19 Nov 2025

https://www.globenewswire.com/news-release/2025/11/18/3190168/0/en/RespireRx-Pharmaceuticals-Inc-Announces-Commencement-of-Rule-506-c-Private-Placement.html

GLOBENEWSWIRE
18 Nov 2025

https://www.globenewswire.com/news-release/2025/11/18/3190170/0/en/RespireRx-Pharmaceuticals-Inc-Announces-SEC-Order-Making-Findings-and-Revoking-Registration-of-Securities-and-Future-Plans-with-respect-to-its-Common-Stock.html

GLOBENEWSWIRE
18 Nov 2025

https://www.globenewswire.com/news-release/2025/02/10/3023315/0/en/RespireRx-Pharmaceuticals-Inc-CFO-and-CEO-Issue-Letter-to-Stockholders-Stakeholders-Strategic-and-Potential-Strategic-Partners-and-Other-Interested-Parties.html

GLOBENEWSWIRE
10 Feb 2025

https://www.globenewswire.com/news-release/2024/05/29/2889855/0/en/RespireRx-Pharmaceuticals-Inc-Announces-a-Department-of-Defense-Award-to-Fund-a-Phase-2-Clinical-Study-to-Determine-the-Safety-and-Efficacy-of-CX1739-its-Lead-AMPAkine-to-Improve-B.html

GLOBENEWSWIRE
29 May 2024

ABOUT THIS PAGE

Contact RespireRx Pharmaceuticals and get a quotation

RespireRx Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of AMPALEX, BULK PHARMACEUTICAL CHEMICAL (BPC) bulk offered by RespireRx Pharmaceuticals

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty